Copper, ceruloplasmin, and long-term cardiovascular and total mortality (The Ludwigshafen Risk and Cardiovascular Health Study)

By Grammer T. B.   Kleber M. E.   Silbernagel G.   Pilz S.   Scharnagl H.   Lerchbaum E.   Tomaschitz A.   Koenig W.   März W.  

Free Radical Research, Vol. 48, Iss. 6, 2014-06 ,pp. : 706-715

Informa Healthcare

Access to resources Recommend Favorite

Is there a role for erythropoietin in cardiovascular disease?

By Vogiatzi Georgia   Briasoulis Alexandros   Tousoulis Dimitris   Papageorgiou Nikolaos   Stefanadis Christodoulos  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 2, 2010-02 ,pp. : 251-264

Informa Healthcare

Access to resources Recommend Favorite

Prostanoid function and cardiovascular disease

By Iniguez Miguel   Cacheiro-Llaguno Cristina   Cuesta Natalia   Diaz-Munoz Manuel   Fresno Manuel  

Archives of Physiology and Biochemistry, Vol. 114, Iss. 3, 2008-07 ,pp. : 201-209

Informa Healthcare

Access to resources Recommend Favorite

Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? - review and recent findings

By Castellani R.J.   Smith M.A.   Nunomura A.   Harris P.L.R.   Perry G.  

Free Radical Biology and Medicine, Vol. 26, Iss. 11, 1999-06 ,pp. : 1508-1512

Elsevier

Access to resources Recommend Favorite

Ceruloplasmin, an Indicator of Copper Status

By Arredondo Miguel   González Mauricio   Olivares Manuel   Pizarro Fernando   Araya Magdalena  

Biological Trace Element Research, Vol. 123, Iss. 1-3, 2008-06 ,pp. : 261-269

Humana Press, Inc

Access to resources Recommend Favorite